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FUNDING  
The study on how practicing in a rural setting may impact upon primary care practitioners, access to 
tests, investigative decisions and attitudes to cancer diagnosis has received no external funding. 
 
HIGHLIGHTS 
• Rural cancer patients are repeatedly demonstrated to have poorer cancer outcomes than 
urban counterparts. 
• In this study we report data from 1,779 representative primary care practitioners from across 
Europe. 
• The study finds compelling evidence that, across Europe, rural primary care practitioners have 
less direct access to cancer investigations. 
• However, the study also finds that rural primary care practitioners across Europe do not delay 
diagnostic action for patients with potential cancer symptoms compared to their urban 
counterparts. 
• Together the results strongly suggest that health service structure and provision, rather than 
physician behaviour, is a much more likely source of rural cancer inequality.  




Rural-dwellers have poorer cancer outcomes than urban counterparts, for reasons which are unclear. 
At healthcare institution level, poorer access to investigations and different clinical decision-making 
by rural primary healthcare practitioners (PCPs) could be important. 
 
Aim 
To compare access to investigations, attitudes to cancer diagnosis and clinical decision-making 
between rural and urban PCPs. 
 
Setting 
A vignette-based cross-sectional survey of rural and urban PCPs in 20 European countries.  
 
Methods 
Data on PCPs’ decision-making and attitudes to cancer diagnosis were based on clinical scenarios. 




Of the 1,779 PCPs completing the survey 541 (30.4%) practiced rurally. Rural PCPs had significantly 
less direct access to all investigative modalities: ultrasound; endoscopy; x-ray and advanced screening 
(all p<0.001). Rural PCPs were as likely as urban PCPs to take diagnostic action (investigation and/or 
referral) at the index consultation in all four clinical vignettes ((OR, 95% CI) for lung: 0.90, 0.72-1.12; 
ovarian: 0.95, 0.75-1.19; breast: 0.87, 0.69-1.09; colorectal: 0.98, 0.75-1.30). Rural PCPs were less likely 
to refer to a specialist at the index consultation for ovarian cancer (OR 0.71 95% CI 0.51-0.99). Rural 
PCPs were significantly more likely to report that their patients faced barriers to accessing specialist 




European rural PCPs report poorer access to investigations but are at least as likely as urban PCPs to 
investigate or refer patients that might have cancer at the index consultation. 
 
Abstract Word Count: 250 words 
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INTRODUCTION 
Rural-dwellers have poorer cancer outcomes compared to city-dwellers but underlying mechanisms 
are poorly understood.[1]. Poorer rural cancer outcomes are important socially and economically since 
24% of Europeans live rurally.[2] Evidence for poorer rural cancer outcomes has accumulated over 
thirty years.[3]. A 1990 case-control study found poorer case-survival rates in non-metropolitan South 
Australians after adjusting for disease stage.[4]. In 2000, a Scottish analysis of 63,976 people diagnosed 
from 1991-1995 found that increasing distance from cancer centres was associated with poorer 
survival for prostate and lung cancer.[5] A Scottish study based on 12,339 people diagnosed with 
common cancers found lower one-year survival among those living more than 60 minutes from a 
cancer centre.[6] More recently, a study of 737,495 people diagnosed with cancer in England between 
2006 and 2010 reported that those living more than 30 minutes from their GP were more likely to 
have an emergency presentation and less likely to have screen-detected cancer.[7] Studies of a Danish 
national cohort of 256,662 cancer patients diagnosed between 2005 and 2016 found that increased 
distance to hospital was associated with longer diagnostic intervals and later stage for harder to 
diagnose cancers.[8,9]   
A recent systematic review reported that, of 39 observational studies from seven countries, most 
showed poorer outcomes for rural patients with cancer.[1] Narrative synthesis of the data suggested 
that inequities can exist at the levels of: the individual patient (their demographics and behavioural 
risk factors); healthcare institutions; urban/rural community environments and culture; and at the 
level of health policy and service organisation.[1] At a healthcare institutions level, rural communities 
could have fewer and less specialised healthcare practitioners, with more limited access to 
investigations.[1]  
Most Europeans with potential cancer symptoms present first to a primary care practitioner (PCP) 
whose decision-making and diagnostic actions will influence the subsequent promptness of cancer 
diagnosis.[10] It seems plausible that geographical setting could influence PCPs’ diagnostic decision-
making when faced with patients who might have cancer. However, we could identify no studies, 
explicitly comparing attitudes to primary care cancer diagnosis and decision-making intentions 
between urban and rural PCPs.  
The Örenäs Research Group is a is a European group of primary care researchers that studies the 
primary care factors that relate to cancer survival. A trans-European collaboration that surveyed PCPs 
in 20 different European countries [11] gathered data from PCPs in rural and urban settings on their 
access to investigations, attitudes and decision-making around cancer diagnosis in primary care. This 
gives the opportunity to explore whether these factors differ significantly between rural and urban 
European PCPs. 




The objectives of this study were to: 
1. Compare rural and urban PCPs’ direct access to cancer investigations. 
2. Compare likelihood that rural or urban PCPs will arrange investigations or referral at the index 
consultation for patients with potential cancer symptoms. 
3. Compare attitudes of rural and urban PCPs to factors associated with cancer diagnosis in 
primary care. 
 
Design and study setting 
The study used data from a cross-sectional Örenäs Research Group electronic survey of PCPs in 20 
European countries.[11]. Development and piloting of the survey has been previously described.[11] 
The survey comprised four sections, with Section 1 seeking demographic information including 
respondents’ own assessment of their practices’ geographical setting (urban, rural, island/remote and 
mixed). Section 2 sought information about availability of relevant investigations. Section 3 comprised 
four clinical vignettes describing symptomatic presentation by four patients, one each with symptoms 
suggestive of lung, colorectal, ovarian and breast cancer, and presented respondents with questions 
about their management decisions. Section 4 comprised twenty statements seeking respondents’ 
attitudes to health system factors that might affect primary care cancer diagnosis. 
 
Participants 
Subjects were eligible for the survey if they were doctors working mainly in primary care. These 
doctors included general practitioners and other doctors with specialist training but working in the 
community and accessible directly by patients without referral. 
 
Recruitment 
An Örenäs Research Group member acted as national lead in each participating country and emailed 
survey invitations to PCPs in their areas, aiming to recruit at least 50 participants. Local leads with 
difficulty achieving required sample sizes increased the number of responses by using snowballing, a 
recognised technique for recruiting hard-to-reach populations in health studies.[12] Consent was 
implied by agreeing to take part. 
 
Data management 
Data were collected using SurveyMonkey (SurveyMonkey, California, USA). Anonymised data were 
extracted by MH and securely transferred to PM to be managed on a secure server at the Institute of 
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Applied Health Sciences, University of Aberdeen, UK. PM, RA and WK had access to the data in full 
compliance with institutional information governance and quality assurance policies. 
 
Data and outcomes 
The following data were extracted from the survey: country of origin; respondents’ characteristics 
(years since graduation, gender); geographical setting of PCP’s practice; access to investigations; 
management decisions based on four clinical vignettes; agreement with 20 statements reflecting 
attitudes to health service factors affecting primary care cancer diagnosis.[13] For each attitudinal 
statement 5-point Likert scale responses were combined into three categories: disagree; neither 
disagree or agree; and agree. 
 
PCPs responding that they worked in an urban, rural or island/remote setting were included. For 
subsequent analysis, we combined rural and island/remote into a single rural variable. We excluded 
those practising in a mixed setting and those with missing values. Country of origin was recoded to 
designate participating countries using the Kringos classification which uses three dimensions to 
designate the strength of national primary care systems.[14] Access to individual investigations was 
re-categorized as access to ultrasound, endoscopy, x-ray and advanced scanning. Four composite 
binary variables, one for each vignette, were produced to indicate if responding PCPs would take 
diagnostic action (investigate directly, refer for investigation and/or refer to secondary care) following 
the index consultation in each vignette. 
 
Statistical analysis 
We compared rural versus urban PCPs by personal characteristics, country and Kringos categories 
using descriptive statistics and the Chi-squared test. We then compared self-reported direct access to 
investigative modalities (ultrasound, endoscopy, x-ray and advanced scanning), overall intention to 
take diagnostic action, and intention to refer to secondary care at the index consultation in each 
clinical vignettes using the Chi-squared test. Unadjusted odds that rural PCPs would take diagnostic 
action or refer to secondary care at each index consultation were compared to those for urban PCPs, 
using univariable binary logistic regression. Subsequent multivariable analysis was used to estimate 
the odds ratios with adjustment for gender, years since graduation, Kringos classification[14] and 
direct access to relevant investigations. Because the proportions of rural respondents varied between 
countries a sensitivity analysis adjusted for country rather than Kringos category was conducted.[14] 
Urban and rural PCPs’ level of agreement with 20 attitudinal statements about health service factors 
were compared using the chi-squared test for trend. To allow for multiple comparisons a simple 
Bonferroni correction (0.05/number of tests) was used where five or more tests were conducted.[15] 




The survey was completed by 2,086 PCPs from 20 European countries. 1238 (59.3%) practiced in an 
urban setting, 485 (23.3%) in a rural setting, 56 (2.7%) in a remote or island setting, 295 (14.1%) in a 
mixed setting, with 12 (0.6%) missing values. The sample for this analysis described in Table 1 
comprised 1,779 individuals of whom 541 (30.4%) were considered rural. Rural PCPs were 47.2% male 
compared to 34.0% of urban respondents (p<0.001) and rural PCPs were significantly more likely to be 
qualified for longer (p<0.001) but no more likely to be qualified in another specialty. After excluding 
PCPs who stated that their geographical location was ‘mixed’, the proportion of rural PCPs ranged 
from 1.8% of French respondents to 71.4% of Swiss respondents (p<0.001). Using the Kringos 
classification urban respondents were significantly more likely to practice in a strong primary care 
system (46.4% versus 39.7%, (p<0.001)).[14] 
 
Rural PCPs reported significantly less direct access to each of the four investigative modalities (all 
p<0.001) (Table 2). The largest difference was for endoscopy, with 923 (74.6%) of urban respondents 
reporting direct access compared to 312 (57.7%) of rural respondents. (Table 2). 
 
The odds of rural PCPs intending diagnostic action (investigation and/or referral) at the index 
consultation was not significantly different from the odds of urban PCPs intending diagnostic action 
for any of the four vignettes following adjustments for gender, years since graduation, Kringos 
classification and direct access to relevant investigations. (Table 3). In sensitivity analysis, adjusting for 
country rather than Kringos system, there were no significant differences between rural and urban 
PCPs in intended diagnostic action. (Supplementary table) 
 
The proportion of rural PCPs intending specialist referral at the index consultation, and the odds 
(unadjusted and adjusted) of specialist referral by rural PCPs did not differ significantly from Urban 
PCPs for the lung or breast vignettes. A significantly lower proportion of urban PCPs intended to refer 
in the colorectal vignette (71.4% vs 78.9%, p<0.001) but the odds of referral by rural PCPs were not 
significantly greater following adjustment (OR 1.30 (95% CI 0.97-1.76). Rural PCPs, however, appeared 
significantly less likely to refer in the ovarian vignette following adjustment (OR 0.71 (95% CI 0.51-
0.99) (Table 4). In sensitivity analysis, adjusted for country rather than Kringos system, there were no 
significant differences in referral intentions of rural or urban PCPs. (Supplementary table) 
 
The comparison of PCPs attitudes is shown in Table 5. More Rural PCPs agreed that referrals were 
welcome and could be made to specialists they knew. More rural PCPs agreed that their patients had 
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greater travelling and costs for to see a specialist, but that costs were met by insurance companies. 
Rural PCPs indicated lower access to fast-track referral pathways but a greater ability for patients to 
self-refer to specialists. Rural PCPs more often agreed they had more time to think within consultations 
and were less likely to refer to reduce workload than urban PCPs. There were no important differences 




Rural PCPs were more likely to be male and to have been qualified for longer. They were less likely to 
have had direct access to all investigative modalities. Rural PCPs were just as likely to intend diagnostic 
action at the index consultation as urban counterparts and were as likely indicate that they would 
refer in three of the four clinical vignettes. Rural PCPs perceived easier access to specialist referral and 
advice and being under less pressure than urban counterparts. Rural PCPs were more likely to agree 
that their patients had more travel and greater cost to be investigated for potential cancer. 
 
Comparison with other literature 
There is some evidence that PCPs are aware of the characteristics of the health system and their 
individual practice or clinic context when making diagnostic decisions.[13,16]. However, we found 
similar diagnostic and referral intentions by rural and urban PCPs in keeping with a New Zealand 
government report that rural and urban GPs had similar referral rates.[17]. Our data contradicts a 
previous survey amongst 100 Tasmanian GPs, where rural respondents believed distance from cancer 
centres influenced patient management and a social survey in 1,603 Norfolk residents partly 
attributing fewer out-patient attendances by rural-dwellers to the influence of access to GP 
behaviour.[18,19]. Neither study measured actual PCP intentions as we have. While both of these 
studies were cited as potentially explanatory by a recent large English study reporting delayed cancer 
diagnosis in rural patients, our data are more current and comprehensive, and downplay differential 
GP referral practices as a root cause of rural cancer inequality.[7] On the other hand Canadian 
researchers found inter-provincial variation in direct GP access to investigations for potential cancer, 
and suggested this could influence GPs’ behaviour and the relative speed of patients’ diagnostic work-
up, a possibility we cannot exclude.[20] Rural GPs are also significantly more likely to undertake 
primary excision of suspicious skin lesions that subsequently prove to be melanoma, a cancer not 
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Strengths and limitations 
This study provides the first trans-European evidence on how healthcare institution factors could 
influence rural cancer outcomes. The study is large and diverse, including responses from 20 European 
countries, and controlling for the range of international healthcare-service delivery models, including 
those with strong, medium and weak traditions of primary care.[14] One third of the sample were 
rural practitioners, close to the proportion of Europe’s population living rurally. The data were 
collected using a robust and carefully developed survey instrument enabling the first meaningful and 
large-scale comparison of geographical variation in PCPs attitudes and decision-making for patients 
with symptoms that could be due to cancer. 
 
Respondents were asked to self-designate the geographical location of their practice, as there is no 
Europe-wide classification of rurality and concepts of rurality may differ across Europe. The proportion 
of urban versus rural respondents varied considerably between responding countries. This may reflect 
differing levels of urbanization in responding countries but may be related to the “snowball” 
recruitment methods used in some participating countries. We included Kringos classification as a co-
variate in adjusted analyses, and a sensitivity analysis using country as a covariate did not alter the 
main results. Respondents practicing in “mixed” geographical settings (n=295, 14% of all respondents) 
were excluded from the analysis. Clinical decision-making comparisons were made using vignettes; 
while these may not be representative of “real-world” decisions, the vignettes were rigorously 
developed using evidence-based methodology.[22] Vignettes were used successfully in an earlier 
study of primary care physicians’ behaviour conducted in Nova Scotia Canada, where the stated 
referral decisions of 225 doctors in response to hypothetical scenarios correlated well with referral 
data for similar cases obtained from health services and insurance records.[23]  Furthermore, a meta-
analysis of 111 vignette-based studies demonstrated further close concordance with participants’ 
observed behaviour.[24] The data were collected in 2016 and it is likely that national health systems 




The finding that rural GPs throughout Europe have less direct access to investigations for patients with 
suspected cancer is important. Policy-makers need to be able to reduce this disparity if they are to 
reduce inequalities in the diagnosis of cancer in rural-dwellers. Improving access to medical 
investigations offers an exciting service design challenge (e.g. point-of-care testing). The finding that 
rural PCPs perceive greater barriers in terms of travel, cost and provision for their patients highlights 
that rural European PCPs are key stakeholders in future research and policy to improve outcomes for 
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their patients who have cancer. Rural PCPs have experienced and reflected on the challenges faced by 
their patients and this will be key in informing how to research and improve rural cancer issues. 
Importantly, rural PCPs appear to be no less likely to make secondary care referrals for patients that 
might have cancer. This contradicts speculation that rural PCPs are influenced by geography when 
making cancer diagnostic decisions, a concern that has been widely voiced and perceived as a potential 
mechanism for rural cancer inequalities. This large and diverse sample provides strong evidence that, 
when consulted by patients that might have cancer, rural PCPs’ investigative instincts and decision-
making are not blunted by their geographical location. There are dual caveats to interpreting the study. 
First, there are differing proportions of rural practitioners in the constituent national samples. Second, 
economic and topographical considerations mean that rurality will likely impact healthcare in different 
ways in different European countries. Whilst adjustments have been made to account for this in the 
current analysis, future collaborative research could be mutually instructive to practitioners and policy 




Rural PCPs throughout Europe report poorer access to investigations for potential cancer than Urban 
PCPs and perceive greater cost, travel and access barriers for their patients. However, rural PCPs across 
Europe are just as likely to refer or investigate patients that might have cancer at the index 
consultation as their urban colleagues.  
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Table 1: Description of the 1,779 respondents to European survey on cancer diagnostics - 1238 urban vs 541 rural/island primary care physicians  
  Urban n (%) Rural n (%) 
GENDER Female 812 (66.0) 282 (52.8) 
 Male 419 (34.0) 252 (47.2) 
 Not Stated 7 7 
 Total 1238 541 
   P<0.0011 
YEARS SINCE GRADUATION Less than 10 220 (17.9) 47 (8.7) 
 10 to 19 315 (25.6) 156 (29.0) 
 20 to 29 357 (29.0) 174 (32.3) 
 30 to 39 292 (23.7) 142 (26.4) 
 40 or more 47 (3.8) 19 (3.5) 
 Prefer not to say 7 3 
 Total 1238 541 
   P=0.0032 
TRAINED IN GP AND ANOTHER SPECIALTY Yes 93 (7.5) 36 (6.7) 
 No 1145 (92.5) 505 (93.3) 
 Total 1238 541 
   P=0.5881 
COUNTRY Bulgaria 44 (3.6) 5 (0.9) 
 Croatia 31 (2.5) 23 (4.3) 
 Denmark 68 (5.5) 14 (2.6) 
 England 28 (2.3) 14 (2.6) 
 Finland 56 (4.5) 6 (1.1) 
 France 54 (4.4) 1 (0.2) 
 Germany 61 (4.9) 42 (7.8) 
 Greece 20 (1.6) 34 (6.3) 
 Israel 66 (5.3) 9 (1.7) 
 Italy 31 (2.5) 24 (4.4) 
 Netherlands 55 (4.4) 56 (10.4) 
 Norway 50 (4.0) 15 (2.8) 
 Poland 108 (8.7) 12 (2.2) 
 Portugal 44 (3.6) 7 (1.3) 
 Romania 108 (8.7) 60 (11.1) 
 Scotland 21 (1.7) 19 (3.5) 
 Slovenia 44 (3.6) 31 (5.7) 
 Spain 302 (24.4) 99 (18.3) 
 Sweden 29 (2.3) 25 (4.6) 
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 Switzerland 18 (1.5) 45 (8.3) 
 Total 1238 541 
   P<0.0013 
KRINGOS CLASSIFICATION Strong 574 (46.4) 215 (39.7) 
Strength of national primary care system Medium 503 (40.6) 255 (47.1) 
 Weak 64 (5.2) 39 (7.2) 
 Unclassified 97 (7.8) 32 (5.9) 
 Total 1238 541 
   P=0.0073 
1Chi-squared test with continuity correction 
2 Chi-squared test for trend 
3 Pearson’s Chi-squared 
Note: Responses of “Prefer not to say” and “Not stated” were excluded from statistical analysis 
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Table 2: Direct access to investigations by urban vs rural primary care physicians in European survey on cancer diagnostics 
  Direct access available to PCP Urban Rural P value1 
ULTRASOUND Yes 1176 (95.0) 480 (88.7)  
 No 62 (5.0) 61 (11.3) P<0.0011 
ENDOSCOPY Yes 923 (74.6) 312 (57.7)  
 No 315 (25.4) 229 (42.3) P<0.0011 
X-RAY Yes 1175 (94.9) 482 (89.1)  
 No 63 (5.1) 59 (10.9) P<0.0011 
ADVANCED SCANNING Yes 825 (66.6) 279 (51.6)  
 No 413 (33.4) 675 (48.4) P<0.0011 
 1 Chi-squared test with continuity correction  
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TABLE 3: Comparison of rural and urban PCPs’ stated diagnostic actions (investigation or referral) at index consultation for each of the four clinical 
vignettes 
  Action taken n (%) No action taken n (%) Unadjusted OR (95% CI) rural vs urban Adjusted OR (95% CI) rural vs urban1 
Lung Cancer Urban 682 (55.1) 556 (44.9)   
 Rural 301 (55.6) 240 (44.4) 1.02 (0.83-1.25) 0.90 (0.72-1.12)1 
Ovarian Cancer Urban 689 (55.7) 549 (44.3)   
 Rural 319 (59.0 222 (41.0) 1.15 (0.93-1.41) 0.95 (0.75-1.19)1 
Breast Cancer Urban 725 (58.6) 513 (41.4)   
 Rural 318 (58.8) 223 (41.2) 1.01 (0.82-1.24) 0.87 (0.70-1.09)1 
Colorectal Cancer Urban 980 (79.2) 258 (20.8)   
 Rural 431 (79.7) 110 (20.3) 1.03 (0.80-1.33) 0.98 (0.75-1.30)1 
1 Adjusted for gender, years since graduation, Kringos classification, direct access to relevant investigations 
 
 
TABLE 4 : Specialist referral made by those taking diagnostic action at index consultation for each of the four clinical vignettes (rural vs urban) including 
unadjusted and adjusted odds that diagnostic action at index consultation is specialist referral (rural vs urban) 




Unadjusted OR (95% CI) 
rural vs urban 
Adjusted OR (95% CI)1 
rural vs urban 
Lung Cancer (n=983) Urban 151 (22.1) 531 (77.9)   
 Rural 78 (25.9) 222 (74.0) 1.23 (0.90-1.69) 1.12 (0.75-1.68)1 
Ovarian Cancer (n=1008) Urban 280 (40.6) 409 (59.4)   
 Rural 116 (36.4) 203 (63.6) 0.84 (0.64-1.10) 0.71 (0.51-0.99)1 
Breast Cancer (n=1043) Urban 513 (70.8) 212 (29.2)   
 Rural 225 (70.8) 93 (29.2) 1.00 (0.75-1.34) 0.94 (0.68-1.30)1 
Colorectal Cancer (n=1411) Urban 700 (71.4) 280 (28.6)   
 Rural 340 (78.9) 91 (21.1) 1.50 (1.14-1.96) 1.30 (0.97-1.76)1 
1 Adjusted for gender, years since graduation, Kringos classification, direct access to relevant investigations
   17 
 
TABLE 5: Comparing rural and urban PCPs attitudes to health service factors affecting diagnosis of cancer in primary care (3-point Likert scale) 
 
  DISAGREE 
 
NEITHER AGREE OR 
DISAGREE 
AGREE P value1,2  
I am able to refer to a specialist that I know personally URBAN n (%) 416 (39.0) 172 (16.1) 480 (44.9) P=0.0011,2 
 RURAL n (%) 142 (30.0) 85 (18.0) 246 (52.0)  
Here specialists usually welcome referrals URBAN n (%) 293 (27.2) 343 (31.8) 441 (40.9) P=0.0011,2 
 RURAL n (%) 101 (21.4) 136 (28.8) 235 (49.8)  
I can easily telephone a specialist for informal discussion URBAN n (%) 303 (28.4) 204 (19.1) 559 (52.4) P=0.0201,2 
 RURAL n (%) 116 (24.5) 75 (15.9) 282 (59.6)  
I am able to refer directly to a named specialist URBAN n (%) 291 (27.0) 96 (8.9) 690 (64.1) P=0.5221,2 
 RURAL n (%) 113 (24.0) 56 (11.9) 302 (64.1)  
My colleagues criticise me if I have referred a patient URBAN n (%) 631 (58.6) 227 (21.1) 218 (20.3) P=0.5321,2 
 RURAL n (%) 273 (57.8) 94 (19.9) 105 (22.2)  
Seeing a specialist can be costly for patients URBAN n (%) 620 (57.8) 123 (11.5) 330 (30.8) P<0.0011,2 
 RURAL n (%) 194 (41.4) 56 (11.9) 219 (46.7)  
We have access to a fast-track specialist appointment system  URBAN n (%) 238 (22.1) 93 (8.6) 746 (69.3) P=0.0061,2 
 RURAL n (%) 129 (27.3) 53 (11.2) 291 (61.5)  
We have a budget or quota for diagnostic tests URBAN n (%) 573 (53.6) 171 (16.0) 325 (30.4) P=0.1761,2 
 RURAL n (%) 266 (57.1) 73 (15.7) 127 (27.3)  
Referral costs are usually paid by insurance companies URBAN n (%) 620 (58.5) 140 (13.2) 300 (28.3) P<0.0011,2 
 RURAL n (%) 216 (46.3) 58 (12.4) 193 (41.3)  
Patients can self-refer to specialists URBAN n (%) 841 (78.5) 105 (9.8) 125 (11.7) P=0.0021,2 
 RURAL n (%) 331 (70.1) 69 (14.6) 72 (15.3)  
In my practice patients often have to travel a long way URBAN n (%) 866 (81.5) 95 (8.9) 101 (9.5) P<0.0011,2 
 RURAL n (%) 230 (49.1) 65 (13.9) 173 (37.0)  
I am very busy and sometimes refer to help reduce my work URBAN n (%) 632 (58.9) 200 (18.6) 241 (22.5) P<0.0011,2 
 RURAL n (%) 328 (69.6) 79 (16.8) 64 (13.6)  
I am likely to refer if a patient requests referral URBAN n (%) 357 (33.2) 267 (24.8) 451 (42.0) P=0.7361,2 
 RURAL n (%) 148 (31.2) 145 (30.5) 182 (38.3)  
We are under media or public pressure to refer earlier URBAN n (%) 343 (31.8) 242 (22.5) 492 (45.7) P=0.3081,2 
 RURAL n (%) 138 (29.0) 111 (23.3) 227 (47.7)  
The local health system encourages us to refer any patients URBAN n (%) 330 (30.7) 272 (25.3) 472 (43.9) P=0.0111,2 
 RURAL n (%) 121 (25.6) 111 (23.5) 240 (50.8)  
I usually have time in the consultation to think carefully URBAN n (%) 334 (31.0) 214 (19.9) 529 (49.1) P=0.0081,2 
 RURAL n (%) 116 (24.5) 96 (20.3) 262 (55.3)  
Common presentations are covered by local or national guidelines URBAN n (%) 145 (13.5) 242 (22.5) 688 (64.0) P=0.7851,2 
 RURAL n (%) 65 (13.9) 96 (20.6) 306 (65.5)  
In general patients prefer a GP to look after them URBAN n (%) 222 (20.5) 424 (39.2) 435 (40.2) P=0.0031,2 
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 RURAL n (%) 69 (14.6) 184 (38.9) 220 (46.5)  
Here high quality care for patient more important than costs URBAN n (%) 152 (14.2) 211 (19.7) 709 (66.1) P=0.6321,2 
 RURAL n (%) 78 (16.5) 80 (16.9) 314 (66.5)  
Referring or not referring doesn’t affect me financially URBAN n (%) 158 (14.8) 136 (12.7) 776 (72.5) P=0.4041,2 
 RURAL n (%) 60 (12.8) 62 (13.2) 346 (73.9)  
 1 P-value from the Chi-squared test for trend with Bonferroni correction applied (accepted level of significance is p=0.05/20 (p=0.0025) 
 
SUPPLEMENTARY TABLE: Comparison of rural and urban PCPs’ stated diagnostic actions (investigation or referral) and likelihood of referral at index 
consultation for those intending action for each of the four clinical vignettes – adjusted for country rather than Kringos classification 
 Adjusted OR for diagnostic action taken 
(95% CI) rural vs urban 
Adjusted OR for specialist referral  
(95% CI) urban vs rural1 
   
Lung Cancer 0.91 (0.72-1.15)1 1.46 (0.92-2.31)1 
   
Ovarian Cancer 0.95 (0.74-1.21)1 0.94 (0.66-1.35)1 
   
Breast Cancer 1.06 (0.83-1.35)1 0.75 (0.52-1.08)1 
   
Colorectal Cancer 0.79 (0.59-1.05)1 1.41(1.02-1.96)1 
1Adjusted for gender, years since graduation, country, direct access to relevant investigations 
 
